Skip to main content
. 2015 Apr 9;32(4):319–340. doi: 10.1007/s12325-015-0200-x

Fig. 4.

Fig. 4

Plasma glucose concentration–time profiles at each dose of luseogliflozin on Days −1, 1, and 7. The plasma glucose concentrations decreased from baseline (Day −1) to Days 1 and 7 in all four luseogliflozin groups. Values are presented as the mean ± standard deviation